Peter Attia· MD
that technology for some of the experimental use that's going on with Alzheimer's disease for the exact same reason it's hitting cytochrome C oxidase
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
that technology for some of the experimental use that's going on with Alzheimer's disease for the exact same reason it's hitting cytochrome C oxidase
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
by the way they're also using methylene blue which is a cytochrome C oxidase activator as well